Hemifacial myohyperplasia
hemi-fay-shul myo-hyper-PLAY-zhuh
Also known as: hemifacial hypertrophy, facial asymmetry syndrome
At a Glance
What is Hemifacial myohyperplasia?
Hemifacial myohyperplasia is a rare condition characterized by the overgrowth of muscle tissue on one side of the face. This condition affects the musculoskeletal system, particularly the facial muscles, leading to noticeable facial asymmetry. It is caused by somatic mutations in the PIK3CA gene, which result in abnormal cell growth. Over time, the asymmetry can become more pronounced, potentially affecting speech and chewing. Early symptoms may include mild facial asymmetry and muscle enlargement, while later symptoms can involve significant functional impairment. Early diagnosis is critical to manage symptoms and prevent complications. The condition can have a significant impact on family life, as it may require ongoing medical care and support. Prognosis varies, but with appropriate management, individuals can lead relatively normal lives. Daily life may involve regular medical check-ups and, in some cases, surgical interventions to improve function and appearance. Treatment options include pharmacological interventions targeting the PIK3CA pathway. Support from healthcare professionals and family is essential to manage the psychological and social aspects of the condition. Despite the challenges, many individuals with hemifacial myohyperplasia adapt well and lead fulfilling lives.
Medical Definition
Hemifacial myohyperplasia is a congenital disorder characterized by unilateral overgrowth of facial muscle tissue due to somatic gain-of-function mutations in the PIK3CA gene. Histologically, it presents with hypertrophic muscle fibers and increased connective tissue. It is classified under overgrowth syndromes and is considered a part of the PIK3CA-related overgrowth spectrum. Epidemiologically, it is an extremely rare condition with an estimated prevalence of 1 in 1,000,000. The disease course is progressive, with symptoms becoming more pronounced over time. Management includes surgical and pharmacological approaches to address both functional and aesthetic concerns.
Hemifacial myohyperplasia Symptoms
Symptoms vary in severity between individuals. Early diagnosis and management can significantly improve outcomes.
Very Common
Facial asymmetry manifests as an uneven appearance of the face, where one side appears larger or more developed than the other. This is caused by overgrowth of the muscles on one side of the face due to somatic PIK3CA gain-of-function mutations. Over time, the asymmetry can become more pronounced, especially during growth spurts in childhood and adolescence. It affects daily life by impacting self-esteem and social interactions, but surgical interventions and pharmacological treatments can help manage the condition.
Muscle hypertrophy in hemifacial myohyperplasia presents as an enlargement of facial muscles on one side. The biological mechanism involves the overactivation of the PI3K-AKT signaling pathway, leading to increased muscle cell growth. This hypertrophy can progress gradually, becoming more noticeable as the individual ages. It can cause functional issues such as difficulty in chewing or speaking, but physical therapy and targeted treatments can alleviate some of these challenges.
Skin thickening appears as a noticeable increase in the thickness of the skin on the affected side of the face. This occurs due to the proliferation of dermal and subcutaneous tissues, driven by the same genetic mutations affecting muscle growth. Over time, the thickening can lead to further asymmetry and potential discomfort. It can affect the patient's daily life by altering facial expressions and sensations, but dermatological treatments can help manage the condition.
Common
Dental malocclusion is characterized by misalignment of the teeth, often seen as an uneven bite. It results from the disproportionate growth of the jaw and facial muscles, affecting dental alignment. As the condition progresses, it can lead to difficulties in chewing and increased wear on certain teeth. Orthodontic interventions can help correct the alignment and improve oral function.
Speech difficulties manifest as challenges in articulation and clarity of speech due to muscle imbalance. The hypertrophy of facial muscles can interfere with the normal movement required for speech production. Over time, these difficulties can impact communication and social interactions. Speech therapy can provide strategies and exercises to improve speech clarity and confidence.
Visual disturbances can occur when the asymmetry affects the eye on the involved side, leading to issues such as ptosis or strabismus. These disturbances arise from the altered muscle tone and pressure around the eye socket. Progression can result in more pronounced vision problems if not addressed. Ophthalmologic evaluation and corrective measures, such as glasses or surgery, can help manage these symptoms.
Less Common
Hearing impairment may present as reduced hearing ability on the affected side due to structural changes in the ear canal or middle ear. The overgrowth of tissues can lead to obstruction or altered function of auditory structures. Over time, this can affect communication and quality of life. Audiological assessments and hearing aids can assist in managing hearing loss.
Nasal obstruction is experienced as difficulty breathing through the nose on the hypertrophied side. This occurs due to the enlargement of nasal structures or deviation of the nasal septum. If left untreated, it can lead to chronic mouth breathing and associated complications. Surgical correction or nasal decongestants can provide relief and improve airflow.
What Causes Hemifacial myohyperplasia?
Hemifacial myohyperplasia is primarily caused by somatic gain-of-function mutations in the PIK3CA gene, located on chromosome 3q26.32. The PIK3CA gene encodes the p110α catalytic subunit of phosphatidylinositol 3-kinase (PI3K), which is crucial for the PI3K/AKT signaling pathway involved in cell growth, proliferation, and survival. Mutations in PIK3CA lead to constitutive activation of the PI3K/AKT pathway, resulting in uncontrolled cellular proliferation and hypertrophy. This hyperactivation causes dysregulation of cellular metabolism and increased anabolic processes, leading to organelle dysfunction, particularly in mitochondria and the endoplasmic reticulum. The aberrant signaling affects neighboring cells by altering the extracellular matrix composition and promoting angiogenesis, contributing to tissue overgrowth. Neuroinflammation may be induced by the abnormal cellular environment, potentially involving microglial activation and cytokine release. This inflammatory response can exacerbate tissue damage and contribute to the degeneration of white matter structures. The specific pattern of hemifacial involvement is due to the mosaic distribution of the mutation, affecting only a subset of cells in the facial musculature. Variability in disease severity among patients is attributed to the timing and extent of the somatic mutation during development, influencing the proportion of affected cells. The localized overgrowth of facial muscles leads to the characteristic asymmetry observed in patients. Additionally, the immune response may vary between individuals, further influencing the clinical presentation. The interplay between genetic, cellular, and environmental factors determines the heterogeneity of symptoms. Understanding these mechanisms provides insight into potential therapeutic targets, such as PI3K inhibitors, which have shown promise in recent studies.
How is Hemifacial myohyperplasia Diagnosed?
Typical age of diagnosis: Hemifacial myohyperplasia is typically diagnosed in early childhood when asymmetry in facial muscle growth becomes apparent. Parents or caregivers often notice the condition due to visible facial asymmetry. Diagnosis is confirmed through a combination of clinical evaluation, imaging studies, and genetic testing. Early diagnosis is crucial for timely intervention and management.
Clinicians look for asymmetry in facial muscle development, focusing on differences in muscle bulk and function. A detailed medical history is taken to rule out other causes of facial asymmetry, such as trauma or congenital syndromes. Physical examination reveals hypertrophy of facial muscles on one side, with no involvement of bone or skin. This step helps differentiate hemifacial myohyperplasia from other conditions like hemifacial hyperplasia or fibrous dysplasia.
Magnetic Resonance Imaging (MRI) is the preferred modality to assess soft tissue structures. MRI shows hypertrophy of the facial muscles without bone involvement, confirming the diagnosis of hemifacial myohyperplasia. These findings help exclude conditions like fibrous dysplasia, which would show bone changes. Imaging also assists in planning further management by delineating the extent of muscle involvement.
Routine laboratory tests are generally not specific for hemifacial myohyperplasia. However, elevated levels of muscle enzymes like creatine kinase may be observed, indicating muscle overactivity. Abnormal results guide clinicians to consider further genetic testing. Laboratory tests are mainly used to rule out other systemic conditions that could present with similar symptoms.
Genetic testing focuses on sequencing the PIK3CA gene, known to harbor gain-of-function mutations in this condition. Mutations such as missense variants confirm the diagnosis of hemifacial myohyperplasia. These results are crucial for confirming the diagnosis and differentiating it from other syndromes with overlapping features. Genetic findings also provide information for family counseling regarding the hereditary nature and recurrence risks.
Hemifacial myohyperplasia Treatment Options
PI3K inhibitors target the PI3K/AKT/mTOR pathway, which is dysregulated due to PIK3CA mutations. These drugs, such as alpelisib, work by reducing abnormal muscle growth. Clinical evidence shows that PI3K inhibitors can decrease muscle hypertrophy and improve facial symmetry. However, side effects like hyperglycemia and gastrointestinal disturbances limit their use. Long-term efficacy and safety data are still being evaluated.
Physical therapy involves specific exercises to balance muscle function and improve symmetry. The goal is to enhance muscle coordination and reduce hypertrophy on the affected side. Sessions are typically conducted twice a week for several months, with progress monitored through muscle strength assessments. Measurable outcomes include improved facial symmetry and functional muscle use. Long-term benefits include maintenance of facial function and prevention of further asymmetry.
Surgery is indicated when there is significant functional impairment or cosmetic concern. The procedure involves resecting hypertrophied muscles to restore facial symmetry. Expected benefits include improved aesthetic appearance and relief from functional issues like difficulty in chewing. Surgical risks include infection, scarring, and potential nerve damage. Post-operative care involves physical therapy to maintain results and prevent recurrence.
The care team includes specialists such as geneticists, plastic surgeons, and physical therapists. Interventions focus on comprehensive management, including medical, surgical, and rehabilitative strategies. Psychosocial support is provided to address the emotional impact of facial asymmetry. Family education is crucial for understanding the condition and its management. Long-term monitoring involves regular follow-ups to assess treatment efficacy and adjust care plans as needed.
When to See a Doctor for Hemifacial myohyperplasia
- Sudden facial asymmetry — this could indicate a rapid progression of the condition or another serious underlying issue.
- Severe pain in the facial muscles — this may suggest complications such as nerve involvement or infection.
- Difficulty breathing or swallowing — these symptoms could indicate compression of vital structures and require immediate medical attention.
- Progressive facial asymmetry — this may indicate worsening of the condition and should be evaluated by a specialist.
- Persistent facial pain — this could be a sign of nerve involvement or other complications and warrants further investigation.
- Difficulty with facial movements — this may suggest muscle involvement or nerve compression and should be assessed by a healthcare provider.
- Mild facial asymmetry — monitor for any changes in symmetry or associated symptoms at home.
- Occasional mild facial discomfort — keep track of any patterns or triggers and discuss with a doctor if it worsens.
Hemifacial myohyperplasia — Frequently Asked Questions
Is this condition hereditary?
Hemifacial myohyperplasia is not typically inherited in a straightforward Mendelian pattern. The condition often arises due to somatic mutations, which are not passed from parent to child. De novo mutations can occur, meaning they are new mutations in the affected individual. Carrier status is not applicable as it is not a hereditary condition in the traditional sense. Genetic counseling may be recommended to discuss the implications of somatic mutations and any potential familial concerns.
What is the life expectancy for someone with this condition?
Life expectancy for individuals with hemifacial myohyperplasia is generally normal, as the condition primarily affects facial muscles. Prognosis can vary depending on the severity and any associated complications. Mortality is not typically directly caused by the condition itself but by potential complications. Treatment, especially early intervention, can improve quality of life and functional outcomes. Realistic expectations include managing symptoms and addressing any aesthetic or functional concerns.
How is this condition diagnosed and how long does diagnosis take?
Diagnosis of hemifacial myohyperplasia involves clinical evaluation, imaging studies, and sometimes genetic testing. The time from first symptoms to diagnosis can vary, often taking months to years due to the rarity of the condition. Specialists such as geneticists, neurologists, and maxillofacial surgeons are typically consulted. Delayed diagnosis may occur due to symptom overlap with other conditions and lack of awareness. Confirmation is usually achieved through a combination of clinical findings and imaging results.
Are there any new treatments or clinical trials available?
Recent research has identified PIK3CA mutations as a target for pharmacological intervention. Gene therapy and targeted molecular treatments are being explored as novel approaches. ClinicalTrials.gov is a resource for finding ongoing trials, and patients should discuss potential participation with their doctor. Questions to ask include eligibility, risks, and potential benefits of trial participation. New treatments may become available in the next few years as research progresses.
How does this condition affect daily life and activities?
Hemifacial myohyperplasia can impact facial symmetry, affecting self-esteem and social interactions. Mobility and self-care are generally not affected, but facial function may be impaired. Educational implications are minimal unless associated cognitive issues are present. Family burden can include emotional stress and the need for medical care coordination. Supportive measures such as counseling and cosmetic interventions can help improve quality of life.
Learn More
Support & Resources
References
Content generated with support from peer-reviewed literature via PubMed.
- 1.Hemifacial myohyperplasia is due to somatic muscular PIK3CA gain-of-function mutations and responds to pharmacological inhibition.
Bayard C, Segna E, Taverne M et al. · J Exp Med · 2023 · PMID: 37712948
- 2.Hemifacial myohyperplasia sequence.
Pereira-Perdomo DF, Vélez-Forero J, Prada-Madrid R · Am J Med Genet A · 2010 · PMID: 20583183
- 3.Progressive Surgical Management of Hemifacial Myohyperplasia for Improved Functional and Aesthetic Results.
Zissman S, Cooperman Y, Leshem D et al. · Plast Reconstr Surg Glob Open · 2020 · PMID: 32802630
- 4.Hemifacial myohyperplasia: description of a new syndrome.
Lee S, Sze R, Murakami C et al. · Am J Med Genet · 2001 · PMID: 11746014
- 5.Lipomatosis: a diverse form of hemifacial hyperplasia.
Arora PC, Umarji HR, Arora A et al. · Imaging Sci Dent · 2012 · PMID: 23071970
- 6.Clinical and imaging features in a patient with hemifacial hyperplasia.
Miranda RT, Barros LM, Santos LA et al. · J Oral Sci · 2010 · PMID: 20881349
- 7.[Diagnostics and treatment of patients with mandible salient angles].
Nabiev FKh, Filippov KV, Libin PV · Stomatologiia (Mosk) · 2011 · PMID: 21983617
- 8.Hemifacial myohyperplasia: an additional case.
Castillo Taucher S, Pardo Vargas RA, Caivi León D · Am J Med Genet A · 2003 · PMID: 12476465
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Last reviewed: 2026-06-10